ALIM Alimera Expected net earnings per share growth this year

Alimera Sciences (ALIM) is growing its capital through global distribution partnerships and the acquisition of retinal therapy assets. Annual earnings per share dynamics reflect market volatility, with the value holding at 84.00. Exclusive implant patents provide a stable income stream, while the expansion of the drug sales network effectively reduces the company's operating expenses.

Alimera Sciences Inc (ALIM) Earnings per share growth in current year: for the period 07/04/2022 - 09/21/2024

Analytical breakdowns and data insights for company Alimera (ALIM)

- stock value and consensus price forecast:

Market Price Alimera|ALIM - Price Target Chart

- market capitalization data:

Market Capitalization Alimera Sciences|ALIM - Enterprise Value

- shareholders' equity book value data:

Book Value per Share Alimera Sciences|ALIM - Company Book Value|Market Value to Book Value Ratio alimerasciences.com|ALIM - Company Total Assets

- debt burden and liquidity indicators:

- earnings and market multiples details:

ALIM - Net Income|Expected Net Income Alimera Sciences|ALIM - Price to Earnings Ratio|Market Cap to Projected Earnings Alimera Sciences Inc|ALIM - PEG Multiple|Enterprise Value to EBITDA Ratio Alimera Sciences|ALIM - Operating profit EBITDA|Net earnings per share for the last four quarters Alimera Sciences|ALIM - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months alimerasciences.com|ALIM - Earnings per share growth in current year|Projected earnings per share growth rate for next year Alimera Sciences

- revenue and sales proceeds data:

ALIM - Revenue and Sales Volume|Company Future Sales Volume Alimera Sciences Inc|ALIM - P/S Multiple|Market Cap to Future Revenue Ratio Alimera Sciences, Inc.

Fundamental valuation:ALIM alimerasciences.com

Mass-produced product of Alimera Sciences Inc

Steady demand for innovative drugs from Alimera Sciences (ALIM) within an independent product cycle renders this asset a defensive tool. By analyzing the shift in earnings per share compared to last year via GURU.Markets, an investor assesses the net income per share dynamics relative to the preceding period. This percentage indicator reveals capital management efficiency, allowing investors to avoid frozen funds during sharp currency fluctuations.

Main competitors